Whether you think it is more like Facebook or LinkedIn, there's no denying that Doximity (NYSE: DOCS) is making a name for itself in digitizing the world of medicine. In this episode of Industry Focus: Wildcard , join Motley Fool contributor Brian Feroldi and Motley Fool analyst Emily Flippen as they break down this new healthcare IPO.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . To get started investing, check out our quick-start guide to investing in stocks . A full transcript follows the video.
For further details see:
Does Doximity Belong on Your Watch List?